ObjectiveÐThe use of synthetic vitreous ®bres has increased along with a decline in the utilisation of asbestos. There remains concern that these synthetic ®bres pose a health risk to workers because of the generation of respirable ®bres which can enter the lung and cause adverse health eects. An improved understanding of the mechanism of ®bre pathogenicity should allow more rational short-term testing regimes for new ®bres as they are developed. We hypothesised that carcinogenic ®bres have greater free radical activity compared with noncarcinogenic ®bres and that they contribute to disease by causing oxidative stress in the lung. We examined a panel of respirable ®bres, designated as being carcinogenic or non-carcinogenic based on previous animal studies for ability to deplete antioxidants from lung lining¯uid.
INTRODUCTION
Exposure to asbestos causes increased risk of pulmonary ®brosis, bronchial carcinoma and pleural mesothelioma and the mechanisms underlying these diseases are only partially understood (Donaldson et al., 1993; Kamp et al., 1992; Kane, 1996) . The use of asbestos in industrial and domestic applications has declined and this has been matched by increased use of synthetic or man-made ®brous materials, in particular mineral wool and ®bres which retain their properties at higher temperaturesÐhigh performance ®bres, such as ceramic ®bres. These ®bres are capable of becoming airborne as respirable ®bres and cause similar diseases to asbestos in rats (Bunn et al., 1993; Mast et al., 1995) . New ®bre types, and variations of existing ®bre types are likely to occur in attempts to improve performance. A number of test protocols have been advanced to test these new ®bres and a number of in vitro tests for predicting toxicity have been suggested (McClellan et al., 1992; Cullen et al., 1997) .
It has been postulated that the surface free radical activity of asbestos ®bres is important in initiating the responses that lead to lung disease (Kamp et al., 1992) and free radical activity is measurable at the surface of asbestos ®bres (Lund and Aust, 1991; Gilmour et al., 1997; Fubini et al., 1995) . The man-made ®bres have less free radical activity (Gilmour et al., 1995) but some refractory ceramic ®bres can be as potent as asbestos in this regard (Brown et al., 1998a) but this depends on the conditions of the assay as we demonstrated with the plasmid scission and salicylic acid assays for detection of ®bre-derived free radicals (Brown et al., 1998a) . Free radicals can interact with lung cells and may cause damage (Kamp et al., 1992) or cell stimulation (Donaldson, 1995; Rahman and MacNee, 1998) . In particular, iron present at the ®bre surface may play a role in the initiation of some of the reactions which produce free radicals via Fenton chemistry (Gilmour et al., 1997; Fubini et al., 1995) . Many genes coding for pro-in¯ammatory molecules, such as cytokines, and adhesion receptors, are controlled by cis-activating regulators of transcription which are activated by oxidative stress, the best known of which is NF-kB (Rahman and MacNee, 1998) . Oxidative stress derived from ®bre surfaces may therefore be pro-inammatory and eventually pathogenic because of its role in signal transduction for transcription of these pro-in¯ammatory genes.
The surfactant system forms a protective barrier in protecting the lung from oxidative and other damage (Slade et al., 1993) . Antioxidant components of this complex mixture which have previously been shown to play a major role include glutathione (GSH) and ascorbate, both of which have been measured in the bronchoalveolar lavagē uid (BAL) of humans (Cantin et al., 1989; Bui et al., 1992) and rats (Jenkinson et al., 1988; Skoza et al., 1983; Willis and Kratzing, 1974) . Depletion of the antioxidant defence screen by pollutants can result in oxidative stress to the underlying epithelial cells (Kelly et al., 1996) .
In this study, we examined the eects of pathogenic or non-pathogenic ®bres for their ability to deplete GSH and ascorbate from rat lung lininḡ uid and lung epithelial cells in vitro.
MATERIALS AND METHODS

Preparation of lung lining¯uid (LLF)
Female Wistar rats aged 3 months were killed with a single injection of Nembutal, the thoracic cavity exposed and the lungs canulated with a blunt needle. Lungs were removed en bloc and lavaged with 7 Â 2 ml volumes of sterile saline at room temperature. After each instillation, the lungs were gently massaged and the lavageate withdrawn and pooled into a single tube. Tubes were spun at 1200 rpm for 5 min to pellet cells and the supernatant transferred to a separate tube. The supernatant (lung lining¯uid) was used in the subsequent treatments.
Fibres
The ®bres used in this study were long ®bre amosite asbestos, silicon carbide ®bre (Advanced Composite Materials Corporation), Refractory Ceramic Fibres from the TIMA repository and man-made vitreous ®bres and Code 100/475 glass ®bres, originally made by Johns Manville. Fibre numbers were based on phase contrast optical microscopy counts of each ®bre type. The size distribution of the ®bres is shown in Table 1 .
Fibre treatment
Conditions were set up to give the same ®bre number per treatment. Fibres were resuspended at 8.24 Â 10 6 ®bres ml À1 LLF and brie¯y sonicated to disperse the ®bres. One millilitre of each ®bre suspension was added to each well of a 24-well plate and incubated at 378C for 4 h with intermittent mixing. After incubation, the ®bre suspensions were transferred to sterile 1.5-ml eppendorf tubes and centrifuged at 2500 rpm for 5 min to pellet the ®bres. The supernatants were transferred to separate tubes for use in the various assays and for GSH extraction. In some experiments, ®bres were suspended at dierent ®bre number in either lung lining¯uid or stock solutions of ascorbate (Sigma, Poole, Dorset) (1 mM) or GSH (reduced form) (Sigma) (12.5 mM) and incubated at 378C for 4 h. 
Oxidant generating system
In order to examine the eect of arti®cially produced oxygen radicals on the antioxidant pro®le of the LLF, the following system based on the method of Simeonova and Luster (1995) , was used. In this system, Fenton chemistry generates powerful oxidising agents, including superoxide and hydroxyl radicals. Brie¯y, stock solutions of ferric sulphate (0.4 mM) and hydrogen peroxide (10 mM) were prepared in Chelex-treated water and 50 ml of each added to 900 ml LLF or pure solutions of GSH and ascorbate. Some treatments consisted of various dilutions of the ferric sulphate/hydrogen peroxide mixture in chelex-treated water. The solutions were incubated at 378C for 4 h and the extraction procedure for GSH/GSSG followed.
Extraction for GSH/GSSG estimations
The method of Akerboom and Sies (1981) was used to extract GSH. The extraction mixture was made up as follows: 50 ml of 70% perchloric acid was diluted to 250 ml with distilled water and stored at 48C (14% perchloric acid). Ten milliliters of 14% perchloric acid, 5 ml distilled water and 180 ml of 0.5 M EDTA were made up to give working strength extraction mixture. Brie¯y, 0.5 ml of treated LLF was pipetted into 15-ml conical tubes and 0.5 ml perchloric acid/EDTA mixture added to each tube to give a ®nal concentration of 0.3 mM. The tubes were mixed and incubated on ice for 15 min. The extraction procedure was carried out in a cold room. After incubation, the tubes were spun at 3000 rpm to pellet any precipitated protein, 1 ml of the supernatant was transferred to clean conical centrifuge tubes and neutralized with 0.5 ml of a solution of 1 M KOH+1 M KHCO 3 . Tubes were mixed until frothing ceased and spun at 3000 rpm for 5 min. One millilitre of the supernatant was then transferred to eppendorf tubes and stored at À808C prior to analysis.
GSH/GSSG assay
The following solutions were prepared:
1. buer consisting of 1.56 g sodium dihydrogen orthophosphate+0.186 g EDTA dissolved in 100 ml distilled water, pH 8.0, made fresh for each assay; 2. o-phthaldehyde (OPT) 1 mg ml À1 in methanol; 3. GSH standards 0.015 g GSH (reduced form) per ml buer giving 0.05 M ®nal concentration; (A standard curve was prepared by further diluting the stock GSH solution 1/100 in buer; 100ml were then added to 900 ml buer to give a ®nal concentration of 50 mM. Further doubling dilutions were made to give a range from 50 to 0.391 mM.)
4. GSSG 0.031 g ml À1 0.1 M NaOH; (Dilutions were made as for the GSH assay using NaOH in place of phosphate buer.); 5. NEM 0.05 g per 10 ml phosphate buer.
Assay. GSH was estimated by pipetting 1.8 ml buer into bijou tubes and adding 100 ml of appropriate standard/sample; 100 ml of OPT was then added to each tube, mixed and incubated at room temperature for 15 min. Each sample was measured in quartz cuvettes using a¯uorimeter set at 350 nm excitation and 420 nm emission. GSSG was estimated by mixing 100 ml of extract (or standard) with 40 ml NEM and incubating at room temperature for 30 min. After incubation, 100 ml of NEM-treated extract was mixed with 1.8 ml 0.1 M NaOH and 100 ml OPT. Tubes were incubated at room temperature for 15 min and read as for the GSH assay.
Ascorbic acid assay
The method used was adapted from that described by Shichi et al. (1997) . Brie¯y, 100 ml of prepared sample (Materials and methods section) were mixed with 50 ml of 6% TCA and incubated in eppendorf tubes at room temperature for 15 min to precipitate protein. Tubes were then centrifuged at 13 000 rpm for 5 min and the supernatant pipetted into fresh tubes. The reagent for the assay consisted of 1% bicinchoninic acid (Sigma) dissolved in buer containing 100 mls distilled Chelexed water, 9.75 g Na 2 CO 3 and 1.34 g NaHCO 3 (Reagent A). Reagent B consisted of a solution of 4% aqueous copper sulphate. The working solution was prepared immediately prior to the assay by mixing solutions A and B in a ratio of 50A:1B.
A series of ascorbate standards were prepared containing TCA at the same concentration as the samples in the range of 1±0.0325 mM; 5 ml of each standard or sample were pipetted into triplicate groups of wells on a 96-well plate and 100 (ml of working strength reagent added to each well. A blank set of wells consisted of TCA with no ascorbate. The plate was incubated at room temperature for 30 min and read at 550 nm on an automatic plate reader. To test that ascorbate was being measured in this assay, a separate series of wells were set up containing 5 ml standard or sample and 2.5 ml of 1 M NaOH. The tests were incubated at room temperature for 30 min prior to the addition of the assay reagent and incubated for a further 30 min at room temperature. Oxidation of ascorbate occurs at alkaline pH, and in these experiments no absorbance was measured after NaOH treatment.
Statistics
Data were analysed using analysis of variance with Tukey multiple comparison test.
RESULTS
Depletion of GSH from lung lining¯uid and from solution
Eect of free radical generating system. We ®rst set out to demonstrate that free radicals do have the ability to deplete the anti-oxidant defences of rat lung lining¯uid. After treatment using an exogenous oxidant generating system, the levels of GSH and ascorbate were measured both in LLF and in pure solutions. Data for GSH depletion in LLF and a pure solution are shown in Fig. 1 . Chemically produced oxidants signi®cantly depleted GSH in LLF and a dilution eect of the generating system was evident. At all concentration ranges for the generating system, there was signi®cant depletion (P < 0.05) of GSH from a pure solution. In LLF, however, GSH was better conserved and although there was depletion at all of the concentrations used, signi®cance was only reached at the two highest concentrations.
Fibres at dierent doses in this series of experiments ®bres were used at the 1Â and 5Â ®bre dose. Increasing the ®bre number to ®ve times that used in original experiments produced a greater depletion of LLF GSH (Fig. 2) . The largest eect was obtained with the two glass ®bres and MMVF10 was most active, almost completely depleting GSH at the 5Â concentration. Statistical analysis showed that at higher ®bre number, there was a signi®cant decrease in GSH compared with the control for all ®bres (P < 0.05) with the exception of RCF1. At the lower ®bre number, only MMVF10 was signi®-cantly dierent from the control. All ®bres were able to deplete GSH from a pure solution at the higher ®bre number (Fig. 3) . At lower ®bre numbers, only Code 100, RCF1 and MMVF10 caused depletion compared with the control, these eects were not signi®cant. At ®ve times normal ®bre number, the greatest depletion was observed with Code 100/475 and MMVF10, all ®bres were signi®-cantly dierent from the control (P < 0.05).
Depletion of ascorbate from lung lining¯uid and in solution
Eect of free radical generating system. Figure 4 shows the same system with ascorbate as the target antioxidant. Although a clear depletion of ascorbate and an eect of oxidant concentration could be demonstrated, this was not statistically signi®cant for LLF. Using a pure ascorbate solution, a signi®-cant eect was noted at the two highest oxidant concentrations (P < 0.05). 6 and 4.12 Â 10 7 ®bres ml À1 . Normalised data represents the mean and SEM of three separate experiments ( * P < 0.05). Fig. 3 . GSH depletion from a 12.5 mM pure solution after 4-h treatment with 8.24 Â 10 6 and 4.12 Â 10 7 ®bres ml À1 . Normalised data represents the mean and SEM of three separate experiments ( * P < 0.05). Eect of ®bres at dierent doses. The data obtained for the ascorbic acid content of the LLF (Figs 5 and 6) after ®bre treatment was similar to the ®nd-ings for GSH, and only the two glass ®bres at the highest dose produced a signi®cant decrease in ascorbate compared with the control. All ®bres, except LFA had the ability to deplete a pure ascorbate solution at the highest dose, although only RCF1 had this activity at the lower dose.
DISCUSSION
The ability of ®bres to cause lung disease has been associated with ®bre dimensions such as length and diameter (Donaldson et al., 1993; Davis and Donaldson, 1986; Stanton et al., 1981) . However, numerous studies have demonstrated that asbestos ®bres have free radical activity (Lund and Aust, 1991) that cause cell damage (Kamp et al., 1992) , activation of transcription factors (Gilmour et al., 1997) and cytokine release (Simeonova and Luster, 1995) . Furthermore, in recent in vivo studies, nonpathogenic ®bres of similar dimensions to pathogenic ®bres have been shown to accumulate in the lung and to persist (Bunn et al., 1993; Davis et al., 1996; Hesterberg et al., 1998) . For instance, although RCF1 was pathogenic in inhalation studies and MMVF10 was not (Bunn et al., 1993) they are similarly biopersistent (Hesterberg et al., 1998) ; thus another explanation for this dierence must be sought. Therefore, while dimensions and durability are probably important in pathogenicity, surface reactivity may also be important. The primary aim of this study was to investigate a panel of three pathogenic and three non-pathogenic ®bres based on data obtained from animal studies (Bunn et al., 1993; Davis et al., 1996) to determine the eect of respirable ®bres on the antioxidants present in lung lining¯uid.
Oxidant stress from ®bres could activate oxidant stress-responsive transcription factors, such as NFkB, leading to the expression of pro-in¯ammatory .24 Â 10 6 and 4.12 Â 10 7 ®bres ml À1 . Normalised data represents the mean and SEM of three separate experiments ( * P < 0.05). Fig. 6 . Ascorbate depletion from a 1 mM pure solution after 4-h treatment with 8.24 Â 10 6 and 4.12 Â 10 7 ®bres ml À1 . Normalised data represents the mean and SEM of three separate experiments ( * P < 0.05).
Depletion of GSH and ascorbate in lung lining¯uidgenes (Rahman and MacNee, 1998) as we have previously demonstrated (Gilmour et al., 1997) . Previous in vitro studies have largely ignored the fact that ®bres entering the lung interact with the surface active lining layer, thereby altering the ®bres' surface chemistry and changing the reactivity with other components of the lung. We have demonstrated that the ®bre surface chemistry and reactivity are important in events which could lead to pathogenic eects of ®bres (Gimour et al., 1997; Brown et al., 1998a; 1998b) . Fibre-derived iron has been implicated in free radical production particularly with asbestos, although MMVF10 ®bres release greater amounts of iron than amphibole asbestos under neutral or acid conditions and in the presence or absence of LLF (Fisher et al., 1998) but MMVF10 is not strongly active in producing free radicals (Brown et al., 1998a) . This is not related to total iron content of the ®bres, since amphibole asbestos has much more total iron, but to biologically active soluble salts of iron. This may be related to the relative importance of free versus surface-bound iron. The balance between free radical production and antioxidant status within the lung is important in normal homeostasis. LLF antioxidant depletion could lead to transmission of oxidative stress to epithelial cells causing increased epithelial permeability (Li et al., 1998) and increased pro-in¯ammatory cytokine production (Rahman and MacNee, 1998) . The present study aimed to examine the antioxidant levels in lung lining¯uid and lung epithelial cells after treatment with three known pathogenic and three known nonpathogenic ®bres. We initially con®rmed that we could deplete antioxidant levels in LLF and pure solutions of GSH and ascorbate with an oxidant generating system. There was a clear dose eect of oxidant in depleting GSH and ascorbate in both LLF and pure solutions. Incubation of LLF with all the dierent ®bres used in this study resulted in a decrease in GSH content. However, the most signi®cant eect was observed with the two glass ®bres, MMVF10 and Code100/475, both designated as being nonpathogenic in animal studies (Davis et al., 1996; Hesterberg et al., 1993) . The eects of these materials was ®bre number dependent, but all ®bres with the exception of RCF1 caused a signi®cant depletion of GSH. These experiments clearly showed that the depletion of GSH in LLF is ®bre number dependent. The two glass ®bres also signi®cantly depleted the ascorbate levels in LLF.
When the ®bre panel was used in experiments where LLF was replaced with pure solutions of either GSH or ascorbate, similar results were obtained. Both of the glass type ®bres, MMVF10 and Code 100/475, produced the most signi®cant (P < 0.05) decrease in GSH compared with control levels. There was a less striking eect when ascorbate levels were estimated in a pure solution after ®bre treatment, where all ®bres depleted ascorbate, but the largest eect was with Code 100/475 and was statistically signi®cant. The MMVF10 ®bre did deplete ascorbate, but there was no obvious pattern with any of the other ®bres. We conclude that there are complex interactions between MMVF10 and the multiple components of the lung lining¯uid and that this contributes to high levels of oxidative stress in this milieu and that these are not present in pure ascorbate solution; the former warrants further research.
We have previously reported (Gilmour et al., 1997) a signi®cant decrease in intracellular GSH with MMVF10 treatment of alveolar macrophages. An interesting ®nding of this study was that MMVF10 had the ability to deplete GSH and ascorbate in solution, since we were unable to detect any hydroxyl radical-generating activity at the surface of this ®bre type (Gilmour et al., 1995; Brown et al., 1998a) . LFA showed the opposite eect, that is no depletion of antioxidants, but strong free radical activity in both a plasmid assay and a salicylic acid hydroxylate assay (Brown et al., 1998a) . Other factors are clearly important for ®bres in terms of the expression of free radical activity in dierent assays and in dierent milieus. The involvement of transition metals co-ordinated at the ®bres surface may be more important than metal released into the surrounding medium (Gilmour et al., 1997; Brown et al., 1998a; Fisher et al., 1998) . Maples and Johnson (1992) also assessed the ability of a range of ®bres to cause mesothelioma after intrapleural instillation. A correlation was demonstrated between mesothelioma formation and the ability of ®bres to generate hydroxyl radicals in the case of naturally occurring ®bres. However, synthetic glass ®bres produced high levels of hydroxyl radical but negligible numbers of mesotheliomas and there was no signi®cant correlation; this is consistent with our ®ndings. We have also reported that MMVF10 can release large amounts of iron (Gilmour et al., 1997) but is not pathogenic.
Oxidative stress in lung cells could arise as an indirect eect of depletion of the LLF antioxidants or could be due to direct eects of ®bre interactions with cells. The present study has shown that antioxidant depletion in LLF is not a reliable discriminator of ®bre pathogenicity based on the six ®bre types used here. Clearly, the production of oxidative stress in the lung is a complex process and the simple in vitro tests used here are not predictive of biological consequences that are clearly multifactorial. Indeed the depletion of antioxidants by noncarcinogenic ®bres could occur in vivo but these ®bres may lack a key feature without which there are no pro-carcinogenic events; by contrast important other eects of the carcinogenic ®bres could lead to genotoxic events. The likely most important result of oxidative stress is the activation of oxidative stress responsive transcription factors leading to gene expression for cytokines and other key molecules (Rahman and MacNee, 1998) . From the data in the present paper, the former seems unlikely. In support of the latter contention, we have shown substantial nuclear translocation of an oxidant stress-responsive transcription factor, NF-kB, in epithelial cells treated with the pathogenic ®bres used here and much less of this activity in cells treated with the non-pathogenic ®bres (Brown et al., 1999) . In vitro tests predicting pathogenicity should continue to bene®t from further understanding of the mechanisms of ®bre pathogenicity and the involvement of oxidative stress remains a fertile ground for development of further tests.
